For the quarter ended September 2025, Xylem (XYL) reported revenue of $2.27 billion, up 7.8% over the same period last year. EPS came in at $1.37, compared to $1.11 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $2.22 billion, representing a surprise of +1.98%. The company delivered an EPS surprise of +10.48%, with the consensus EPS estimate being $1.24.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Xylem performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Xylem here>>>
Shares of Xylem have returned +3.8% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Aug-19 | |
| Aug-18 | |
| Aug-13 | |
| Aug-13 | |
| Aug-11 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-15 | |
| Jul-02 | |
| Jun-30 | |
| May-26 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite